At the 2025 U.S.–China Forum on Health Innovation and Collaboration in Shanghai, Rochester Mayor Kim Norton presented DMC’s US $6 billion health-innovation project, while BioTech (Shanghai) and SaniMed Science Group led discussions on AI, FDA readiness, and global expansion—strengthening U.S.–China partnerships and empowering Chinese MedTech firms to enter the U.S. market.

BioTech (Shanghai) Chairman Jim Wu attended the 2025 Heartland Connect for Trade & Investment Conference, hosted by USHCA, engaging leaders from Mayo Clinic’s DMC and U.S. healthcare organizations. The event fostered dialogue on AI, healthcare access, and innovation, advancing U.S.–China collaboration and helping Chinese MedTech firms enter the American market.